| Sign In to gain access to subscriptions and/or personal tools. |
Integrin signalling defects in T-lymphocytes in systemic lupus erythematosus
Department of Immunology, St Bartholomew's and the Royal London School of Medicine and Dentistry, London
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington, USA
Wellcome Trust Centre for Cell-Matrix Research, School of Biological Sciences, University of Manchester, Manchester, UK
Department of Immunology, St Bartholomew's and the Royal London School of Medicine and Dentistry, London;Present address; Department of Rheumatology, University of Birmingham Medical School, UK
Department of Haematology, Royal Free Hospital, London, UK
Department of Rheumatology, St Bartholomew's and the Royal London School of Medicine and Dentistry, London
Department of Immunology, St Bartholomew's and the Royal London School of Medicine and Dentistry, London;Department of Immunology, 38 Little Britain, London EC1A 7BE, UK.
Department of Immunology, St Bartholomew's and the Royal London School of Medicine and Dentistry, London Objective: To establish the relationship between T cell responses to integrin coreceptor stimulation and B cell hyperreactivity as measured by pathologic autoantibody production. Methods: Peripheral blood mononuclear cells from 42 patients with SLE according to the American Rheumatism Association criteria were examined for their ability to adhere to plateimmobilised fibronectin. Co-stimulation assays were performed on the same cells using anti-CD3 antibody alone or co-immobilised with an anti-b1-integrin antibody. Proliferative responses were measured by 3[H]thymidine pulsing on day 3 and activation was determined using a commercial protein kinase C assay, the protocol being established by our group in association with Promega. b1-Integrin expression was established by FACS analysis. Results: An impaired PKC response to integrin-mediated activation was found in T-lymphocytes from 6=21 (29%) SLE patients, which correlated significantly with an absence of anti-dsDNA antibody in patient sera, irrespective of prednisolone treatment. Integrin co-stimulation of TcR/CD3-induced proliferation and T cell adhesion to fibronectin were also impaired among 5=21 (24%) and 6=15 (40%) patients studied, respectively. Conclusion: We hypothesise that the integrity of b1-integrin signalling pathways may influence pathological antibody production in SLE by affecting T-lymphocyte activation and interactions between T and Blymphocytes.
Key Words: fibronectin integrin protein kinase C signalling SLE T cell co-stimulation
Lupus, Vol. 8, No. 1,
39-51 (1999) This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
